Company intelligence / Profile preview

Medable

Palo Alto, California, United Statesmedable.com ↗

Ownership: Private
Development stage: Commercial

Overview

Medable’s technology has enabled clinical trial sponsors to achieve up to 200% faster patient enrollment and 50% cost reductions. The company’s decentralized approach has been linked to improved access for underrepresented communities and enhanced data quality in clinical research. Its long-term follow-up model for cell & gene therapy trials addresses regulatory requirements and reduces burden on patients/sites.

Therapeutic areas: OtherOncologyRare DiseasesInfectious Diseases
Modalities: small moleculesbiologicscell and gene therapies
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Google Cloud (collaboration to deliver digital clinical trial tech on Google Cloud Marketplace)GSKSyneos Health

Beyond the preview

Go deeper on Medable.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medable.

Explore the full profile